Genetically modifying individual cells in animals
Researchers around Randall Platt have developed a method that lets them genetically modify each cell differently in animals. This allows them to study in a single experiment what used to require many animal experiments. Using the new method, the researchers have discovered genes that are relevant for a severe rare genetic disorder.
In brief
- Researchers combined the modification of many genes in living adult animals using the CRISPR-Cas gen scissors with the subsequent analysis of single cells.
- This lets them switch off different genes in the individual cells of an organ, thus creating a mosaic of genetically different cells, and study the effects.
- The method simplifies and accelerates animal research and is particularly suitable for studying diseases with complex genetic causes.
One proven method for tracking down the genetic causes of diseases is to knock out a single gene in animals and study the consequences this has for the organism. The problem is that for many diseases, the pathology is determined by multiple genes. This makes it extremely difficult for scientists to determine the extent to which any one of the genes is involved in the disease. To do this, they would have to perform many animal experiments – one for each desired gene modification.
Researchers led by Randall Platt, Professor of Biological Engineering at the Department of Biosystems Science and Engineering at ETH Zurich in Basel, have now developed a method that will greatly simplify and speed up research with laboratory animals: using the CRISPR-Cas gene scissors, they simultaneously make several dozen gene changes in the cells of a single animal, much like a mosaic. While no more than one gene is altered in each cell, the various cells within an organ are altered in different ways. Individual cells can then be precisely analysed. This enables researchers to study the ramifications of many different gene changes in a single experiment.
First time in adult animals
For the first time, the ETH Zurich researchers have now successfully applied this approach in living animals – specifically, in adult mice – as they report in the current issue of Nature. Other scientists had previously developed a similar approach for cells in culture or animal embryos.
To “inform” the mice’s cells as to which genes the CRISPR-Cas gene scissors should destroy, the researchers used the adeno-associated virus (AAV), a delivery strategy that can target any organ. They prepared the viruses so that each virus particle carried the information to destroy a particular gene, then infected the mice with a mixture of viruses carrying different instructions for gene destruction. In this way, they were able to switch off different genes in the cells of one organ. For this study, they chose the brain.
New pathogenic genes discovered
Using this method, the researchers from ETH Zurich, together with colleagues from the University of Geneva, obtained new clues to a rare genetic disorder in humans, known as 22q11.2 deletion syndrome. Patients affected by the disease show many different symptoms, typically diagnosed with other conditions such as schizophrenia and autism spectrum disorder. Before now, it was known that a chromosomal region containing 106 genes is responsible for this disease. It was also known that the disease was associated with multiple genes, however, it was not known which of the genes played which part in the disease.
Read on >> find full-length ETH News.
Perturbing the genome
The technique presented here is one of a series of new genetic editing methods used to alter the genome of cells in a mosaic-like manner. CRISPR perturbation is the technical term for this research approach that involves the perturbation of the genome using CRISPR-Cas gene scissors. This approach is currently revolutionising research in the life sciences. It makes it possible to obtain a great deal of information from a single scientific experiment. As a result, the approach has the potential to accelerate biomedical research, such as in the search for the molecular causes of genetically complex diseases.
A week ago, another research group from the Department of Biosystems Science and Engineering at ETH Zurich in Basel, working with a team from Vienna, published a study in which they applied CRISPR perturbation in organoids (see ETH News). Organoids are microtissue spheroids that are grown from stem cells and have a similar structure to real organs – in other words, they are a sort of miniature organ. They are an animal-free research method that complements research on animals. Because both methods – CRISPR perturbation in animals and in organoids – can provide more information with fewer experiments, both have the potential to ultimately reduce the number of animal experiments.
This is a shortened version of ETH News.
Find the research article published by Nature:
Santinha AJ, Klingler E, Kuhn M, Farouni R, Lagler S, Kalamakis G, Lischetti U, Jabaudon D, Platt RJ (2023) Texternal page ranscriptional linkage analysis with in vivo AAV-Perturb-seq. Nature, 20 September 2023, doi:10.1038/s41586-023-06570-y
Learn about research in the Biological Engineering lab led by Randall Platt.